Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...

Tresiba (insulin degludec) and Lantus (insulin glargine ... of body weight daily Administer Tresiba and Lantus subcutaneously once daily at any time of day but at the same time every day.

Novo Nordisk's long-acting insulin Tresiba is set to gain new hypoglycaemia ... In particular, it will give Tresiba an edge over Lantus in a highly competitive market, where biosimilars are ...

Novo Nordisk's long-acting insulin Tresiba is set to gain new hypoglycaemia ... In particular, it will give Tresiba an edge over Lantus in a highly competitive market, where biosimilars are ...